VAGELOS P ROY - Director at REGENERON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by VAGELOS P ROY since 05 Feb 2025

Holdings reported by VAGELOS P ROY for REGENERON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 312,578 $297,342,948 $951.26 03 Apr 2023 Direct
Common Stock 125,493 $119,376,471 $951.26 03 Apr 2023 by CLAT
Common Stock 23,461 $22,317,511 $951.26 03 Apr 2023 by Spouse as Trustee
Common Stock 3,609 $3,433,097 $951.26 03 Apr 2023 by trust for grandch
Common Stock 1,963 $1,867,323 $951.26 03 Apr 2023 By 401(k) Plan
Non-Qualified Stock Option (right to buy) 85,000 22 Feb 2023 Direct Common Stock

Transactions reported by VAGELOS P ROY for REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.